Federal Register / Vol. 66, No. 45 / Thiirsday, March 7, 1991 / Notices 
9707 
project beyond the federally-funded 
project period. 
The proposed priority does not 
preclude ^ding of other eligible 
approved applications. Accordingly, 
entities which do not qualify for or elect 
to request consideration for the 
proposed priority are encouraged to 
submit applications. 
Interested persons are invited to 
comment on the proposed definitions 
and funding priority. Normally, the 
comment period would be 60 days. 
However, due to the need to implement 
this new program in Fiscal Year 1991, 
this comment period has been reduced 
to 30 days. All comments received on or 
before April 8, 1991, will be considered 
before the final definitions and funding 
priopty are established. No funds will 
be allocated or final selections made 
until a final notice is published stating 
whether the definitions and funding 
priority will be applied. 
Written comments should be 
addressed to: Director, Division of 
Disadvantaged Assistance, Bureau of 
Health Professions, Health Resources 
and Services Administration, Parklawn 
Building, room 8A-09, 5600 Fishers Lane, 
Rockville, Maryland 20857. 
All comments received will be 
available for public inspection and 
copying at the Division of 
Disadvantaged Assistance, Bureau of 
Health Professions, at the address above 
weekdays (Federal holidays excepted] 
between the hours of 8:30 a.m. and 5 
p.m. 
Application Requests 
Requests for application material and 
questions regarding grants policy should 
be directed to: Grants Management 
Officer (D34), Bureau of Health 
Professions, Health Resources and 
Services Administration, 5600 Fishers 
Lane, room 8C-22, Rockville, Maryland 
20857, telephone: (301) 443-6857. 
Completed applications should be 
forwarded to the Grants Management 
Officer at the above address. 
Questions regarding programmatic 
information should be directed to: 
Division of Disadvantaged Assistcince, 
Bureau of Health Professions, Health 
Resources and Services Administration, 
5600 Fishers Lane, room 8A-09, 
Rockville, Maryland 20857, telephone: 
(301) 443-2100. 
To receive consideration, applications 
must meet the deadline of April, 8, 1991, 
which means they must either be: 
1, Received on or before the deadline 
date, or 
2. Postmarked on or before the 
deadline and received in time for 
submission to an independent review 
group. A legibly dated receipt from a 
commerical carrier or the U.S. Postal 
Service will be accepted in lieu of a 
postmark. Private metered postmarks 
shall not be acceptable as proof of 
timely mailing. 
Late applications not accepted for 
processing will be returned to the 
applicant. 
The standard application form, PHS 
6025-1, HRSA Competing Training Grant 
Application and General Instructions 
have been approved by the Office of 
Management and Budget under the 
Paperwork Reduction Act The OMB 
clearance number is 0915-0060. The 
Program, Grants for Center of 
Ex'^ellence in Minority Health 
Professions Education is listed at 93.157 
in the Catalog of Federal Domestic 
Assistance. Applications submitted in 
response to this announcement are not 
subject to the provisions of Executive 
Order 12372, Intergovernmental Review 
of Federal Programs (as implemented 
through 45 CFR part 100). 
Dated: March 1, 1991. 
Robert G. Harmon, 
Administrator. 
[FR Doa 91-6353 Filed 3-6-91; 8:45 am] 
MLUNO CODE 4160-1$-M 
National Institutes of Health 
Division of Research Grants Meeting 
of the Division of Research Grants 
Advisory Committee 
Pursuant to Public Law 92-463, notice 
is hereby given of the meeting of the 
Division of Research Grants Advisory 
Committee, April 8, 1991, Conference 
Room 10, Building 3lG National 
Institutes of Health, 9000 Rockville Pike, 
Bethesda, Maryland 20892. 
The entire meeting will be open to the 
public from 8:30 ajn. to 4:30 p.m. The 
one-day meeting will include a 
discussion of the development of the 
electronic grant application and a draft 
NIH plan for managing the costs of 
biomedical research. Attendance by the 
public will be limited to space available. 
The Office of Committee 
Management Division of Research 
Grants, Westwood Building, National 
Institutes of Health, Bethesda, Maryland 
20892, telephone (301) 496-7534, will 
furnish a summary of the meeting and a 
roster of the committee members. 
Dr. Samuel Joseloff, Executive 
Secretary of the Committee, Westwood 
Building, Room 449, National Institutes 
of Health, Bethesda, Maryland 20892, 
phone (301) 496-7441, will provide 
substantive program information upon 
request. 
Dated: February 8, 1991. 
Betty J. Beveridge, 
Committee Management Officer, NIH. 
[FR Doc. 91-5326 Filed 3-6-91; 8:45 am] 
BILLINQ CODE 4140-01-M 
National Heart, Lung, and Blood 
Institute; Meeting of the Cardiology 
Advisory Committee 
Pursuant to Public Law 92-463, notice 
is hereby given of a meeting of the 
Cardiology Advisory Committee, 
National Heart, Limg, and Blood 
Institute, March 25-26, 1991, Building 
3lC, Conference Room 8, National 
Institutes of Health, 9000 Rockville Pike, 
Bethesda, Maryland 20892. 
The entire meeting will be open to the 
public from 9 a.m. on March 25 to 
adjournment on March 26. Attendance 
by the public will be limited to space 
available. Topics for discussion will 
include a review of the research 
programs relevant to the Cardiology 
area and consideration of future needs 
and opportunities. 
Terry Bellicha, Chief. Communications 
and Public Information Branch, National 
Heart, Lung, and Blood Institute, Toom 
4A21, Building 31, National Institutes of 
Health, Bethesda, Maryland 20892, (301) 
496-4236, will provide a summary of the 
meeting and a roster of the committee 
members. 
Michael J. Horan, M.D., Associate 
Director for Cardiology, Division of 
Heart and Vascular Diseases, National 
Heart, Lung, and Blood Institute, room 
320, Feder^ Building, Bethesda, 
Maryland 20892, (301) 496-5421, will 
furnish substantive program information 
upon request. 
(Catalog of Federal Domestic Assistance 
Program No. 13.837, Heart and Vascular 
Diseases Research, National Institutes of 
Health) 
Dated: February 28, 1991. 
Betty J. Beveridge, 
Committee Management Officer, NIH. 
[FR Doc. 91-5325 Filed 3-8-91; 8:45 am] 
BHJJNO CODE 4140-01-M 
Human Gene Therapy Subcommittee; 
Meeting 
Pursuant to Public Law 92-463, notice 
is hereby given of a meeting of the 
Human Gene Therapy Subcommittee (a 
subcommittee of the Recombinant DNA 
Advisory Committee) on April 5, 1991. 
The meeting will be held at the National 
Institutes of Health (NIH), Building 31, 
Conference Room 6, 9000 Rockville Pike, 
Bethesda, Maryland 20892, starting at 
[ 552 ] 
Recombinant DNA Research, Volume 14 
